Vivos Therapeutics Inc (VVOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | 12-2005 | |
| Sales | 13,066 | 11,393 | 0 | 0 | 0 |
| Cost of Goods | 2,653 | 2,736 | N/A | N/A | N/A |
| Gross Profit | 10,413 | 8,657 | N/A | N/A | N/A |
| Operating Expenses | 23,106 | 19,971 | 0 | 0 | 0 |
| Operating Income | -12,040 | -10,577 | N/A | N/A | N/A |
| Interest Expense | 96 | 138 | 0 | 0 | 0 |
| Other Income | 79 | -39 | 0 | 0 | 0 |
| Pre-tax Income | -12,057 | -10,754 | 0 | 0 | 0 |
| Net Income Continuous | -12,057 | -10,754 | N/A | N/A | N/A |
| Net Income | $-12,057 | $-10,754 | $N/A | $N/A | $N/A |
| EPS Basic Total Ops | -35.00 | -23.75 | N/A | N/A | N/A |
| EPS Basic Continuous Ops | -23.42 | -21.80 | N/A | N/A | N/A |
| EPS Diluted Total Ops | -35.00 | -23.75 | N/A | N/A | N/A |
| EPS Diluted Continuous Ops | -23.42 | -21.80 | N/A | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | -35.00 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-11,322 | $-9,826 | $N/A | $N/A | $N/A |